Go Pro

Angi (ANGI) Financials

Angi logo
$5.53 +0.11 (+2.03%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$5.50 -0.03 (-0.54%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Angi

Annual Income Statements for Angi

This table shows Angi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-1.33 13 -103 77 35 -7.50 -71 -128 -41 36 44
Consolidated Net Income / (Loss)
-4.00 11 -105 78 35 -5.38 -70 -128 -40 37 44
Net Income / (Loss) Continuing Operations
-4.00 11 -105 78 35 -4.16 -64 -89 -30 37 44
Total Pre-Tax Income
-2.24 22 -154 70 34 -19 -94 -95 -28 20 63
Total Operating Income
-1.57 24 -148 64 39 -6.37 -68 -76 -26 22 65
Total Gross Profit
338 473 702 1,077 1,280 1,295 1,345 1,427 1,296 1,128 983
Total Revenue
361 499 736 1,132 1,326 1,468 1,619 1,764 1,359 1,185 1,031
Operating Revenue
361 499 736 1,132 1,326 1,468 1,619 1,764 1,359 1,185 1,031
Total Cost of Revenue
23 26 34 56 46 173 275 337 63 58 47
Operating Cost of Revenue
23 26 34 56 46 173 275 337 63 58 47
Total Operating Expenses
340 449 850 1,013 1,241 1,301 1,413 1,503 1,323 1,106 918
Selling, General & Admin Expense
87 110 300 323 348 374 395 447 359 320 263
Marketing Expense
226 307 464 541 733 763 872 890 765 602 508
Research & Development Expense
17 21 48 61 64 69 71 74 97 95 87
Depreciation Expense
6.59 8.42 15 24 40 53 59 78 94 86 45
Amortization Expense
3.84 3.15 23 62 55 43 16 14 7.96 2.60 1.80
Restructuring Charge
- - - - - - - - 0.00 0.00 13
Total Other Income / (Expense), net
-0.67 -1.59 -5.76 6.12 -5.00 -14 -26 -19 -1.71 -1.81 -2.88
Interest Expense
0.27 0.89 7.74 12 11 14 23 20 20 20 20
Other Income / (Expense), net
-0.40 -0.70 1.97 18 6.49 - -2.51 1.17 18 18 18
Income Tax Expense
1.76 12 -49 -7.48 -1.67 -15 -30 -5.39 1.84 -17 19
Net Income / (Loss) Discontinued Operations
- - - - - - -6.48 -39 -10 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-2.67 -2.50 -1.41 0.19 0.49 2.12 0.88 0.47 0.63 0.84 0.00
Basic Earnings per Share
$0.00 $0.03 ($0.24) $0.16 $0.07 ($0.01) ($0.14) ($0.26) ($0.81) $0.72 $0.96
Weighted Average Basic Shares Outstanding
- 437.60M 430.61M 483.20M 497.60M 500.05M 501.63M 504.78M 502.03M 498.45M 40.10M
Diluted Earnings per Share
$0.00 $0.03 ($0.24) $0.15 $0.07 ($0.01) ($0.14) ($0.26) ($0.81) $0.71 $0.94
Weighted Average Diluted Shares Outstanding
- 437.60M 430.61M 483.20M 497.60M 500.05M 501.63M 504.78M 502.03M 498.45M 40.10M
Weighted Average Basic & Diluted Shares Outstanding
- 437.60M 430.61M 483.20M 497.60M 500.05M 501.63M 504.78M 502.03M 498.45M 40.10M

Quarterly Income Statements for Angi

This table shows Angi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-5.36 -5.56 -1.63 3.76 35 -1.29 15 11 11 7.22 -8.98
Consolidated Net Income / (Loss)
-5.29 -5.55 -1.32 4.09 35 -1.29 15 11 11 7.22 -8.98
Net Income / (Loss) Continuing Operations
-2.95 2.48 -1.32 4.09 35 -1.29 15 11 11 7.22 -8.98
Total Pre-Tax Income
-9.01 8.14 2.16 8.72 8.75 0.45 20 17 21 4.50 -9.70
Total Operating Income
-7.86 7.63 2.72 9.19 7.82 2.17 20 18 22 5.95 -9.46
Total Gross Profit
338 283 293 301 282 252 233 265 253 232 228
Total Revenue
351 300 305 315 297 268 246 278 266 241 238
Operating Revenue
351 300 305 315 297 268 246 278 266 241 238
Total Cost of Revenue
14 17 12 14 15 16 13 13 12 8.82 9.69
Operating Cost of Revenue
14 17 12 14 15 16 13 13 12 8.82 9.69
Total Operating Expenses
345 276 290 292 274 250 213 247 231 226 238
Selling, General & Admin Expense
99 71 86 84 77 73 57 74 69 62 58
Marketing Expense
200 157 157 158 155 131 119 139 129 120 140
Research & Development Expense
21 24 24 25 24 23 27 24 21 16 10
Depreciation Expense
22 24 24 24 18 20 9.95 10 12 13 15
Restructuring Charge
- - - - - - 0.00 - - - 15
Total Other Income / (Expense), net
-1.15 0.51 -0.55 -0.47 0.93 -1.72 -0.22 -0.23 -0.98 -1.45 -0.23
Interest Expense
5.04 5.04 5.04 5.04 5.05 5.05 5.04 5.05 5.07 5.31 5.33
Other Income / (Expense), net
3.89 5.55 4.48 4.57 5.98 3.33 4.83 4.82 4.09 3.85 5.10
Income Tax Expense
-6.06 5.65 3.48 4.63 -27 1.73 4.68 6.54 10 -2.73 -0.72
Basic Earnings per Share
($0.01) ($0.01) ($0.03) $0.07 $0.71 ($0.01) $0.30 $0.23 $0.24 $0.18 ($0.22)
Weighted Average Basic Shares Outstanding
507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M 44.34M 43.15M 40.10M 40.45M
Diluted Earnings per Share
($0.01) ($0.01) ($0.03) $0.07 $0.70 ($0.01) $0.30 $0.23 $0.23 $0.18 ($0.22)
Weighted Average Diluted Shares Outstanding
507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M 44.34M 43.15M 40.10M 40.45M
Weighted Average Basic & Diluted Shares Outstanding
507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M 44.34M 43.15M 40.10M 40.45M

Annual Cash Flow Statements for Angi

This table details how cash moves in and out of Angi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2.12 45 173 234 52 422 -384 -127 72 52 -113
Net Cash From Operating Activities
18 48 42 224 214 188 6.21 27 94 156 105
Net Cash From Continuing Operating Activities
18 48 42 224 214 188 25 46 94 156 105
Net Income / (Loss) Continuing Operations
-4.00 11 -105 78 35 -4.16 -64 -89 -30 37 44
Consolidated Net Income / (Loss)
-4.00 11 -105 78 35 -4.16 -70 -128 -40 37 44
Net Income / (Loss) Discontinued Operations
- - - - - - -6.48 -39 -10 0.00 0.00
Depreciation Expense
6.59 8.42 15 24 40 53 59 78 94 86 45
Amortization Expense
3.84 3.15 23 62 55 43 16 14 7.96 2.60 1.80
Non-Cash Adjustments To Reconcile Net Income
22 27 176 131 142 177 145 171 113 108 69
Changes in Operating Assets and Liabilities, net
-11 -1.79 -67 -71 -59 -80 -132 -127 -90 -77 -55
Net Cash From Discontinued Operating Activities
- - - - - - -18 -19 - 0.00 0.00
Net Cash From Investing Activities
-10 -32 -93 -58 -41 -104 -19 -115 -47 -50 -59
Net Cash From Continuing Investing Activities
-10 -32 -93 -58 -41 -104 -19 -115 -47 -50 -59
Purchase of Property, Plant & Equipment
-10 -17 -27 -47 -69 -52 -70 -115 -48 -50 -60
Purchase of Investments
- 0.00 0.00 -60 0.00 -100 0.00 0.00 -12 0.00 0.00
Sale of Property, Plant & Equipment
- - 0.00 10 0.00 0.02 0.00 0.16 0.09 0.08 0.15
Divestitures
- - 0.00 3.67 24 0.73 0.75 0.00 1.00 0.00 0.00
Sale and/or Maturity of Investments
- - 0.00 35 25 50 50 0.00 13 0.00 0.00
Net Cash From Financing Activities
-9.52 29 225 -49 -122 337 -345 -17 -17 -54 -158
Net Cash From Continuing Financing Activities
-9.52 29 225 -49 -122 337 -345 -17 -17 -54 -158
Repayment of Debt
0.00 -11 -185 -18 -15 -34 -220 -0.26 -0.06 -0.01 -1.68
Repurchase of Common Equity
- - 0.00 0.00 -57 -64 -35 -8.14 -11 -29 -149
Payment of Dividends
0.00 -0.21 -13 -6.06 -0.07 -4.28 -28 0.00 0.00 -16 0.00
Other Financing Activities, net
-9.53 -4.31 16 -25 -46 -61 -62 -8.83 -5.99 -9.13 -7.98
Effect of Exchange Rate Changes
-0.32 - - 0.21 - - -0.05 -1.11 - 0.47 -0.12
Other Net Changes in Cash
- - - 117 - - -44 -20 42 0.00 0.00

Quarterly Cash Flow Statements for Angi

This table details how cash moves in and out of Angi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-3.76 7.77 -0.71 37 -4.93 21 -30 -24 -22 -37 -59
Net Cash From Operating Activities
11 16 22 63 31 40 -3.11 57 21 30 -18
Net Cash From Continuing Operating Activities
8.21 8.94 22 63 31 40 -3.11 57 21 30 -18
Net Income / (Loss) Continuing Operations
-2.95 2.48 -1.32 4.09 35 -1.29 15 11 11 7.22 -8.98
Consolidated Net Income / (Loss)
-5.29 -5.55 -1.32 4.09 35 -1.29 15 11 11 7.22 -8.98
Depreciation Expense
22 24 24 24 18 20 9.95 10 12 13 15
Non-Cash Adjustments To Reconcile Net Income
34 27 30 30 26 22 10 19 21 19 13
Changes in Operating Assets and Liabilities, net
-48 -44 -31 4.62 -48 -3.23 -39 17 -23 -11 -36
Net Cash From Investing Activities
-14 -11 -13 -13 -12 -13 -12 -12 -16 -19 -16
Net Cash From Continuing Investing Activities
-14 -11 -13 -13 -12 -13 -12 -12 -16 -19 -16
Purchase of Property, Plant & Equipment
-14 -12 -13 -13 -12 -13 -13 -12 -16 -19 -16
Sale of Property, Plant & Equipment
- 0.07 0.01 - - 0.08 0.08 - - 0.07 0.03
Net Cash From Financing Activities
-0.66 -8.75 -10 -13 -24 -6.22 -14 -69 -26 -49 -26
Net Cash From Continuing Financing Activities
-0.66 -8.75 -10 -13 -24 -6.22 -14 -69 -26 -49 -26
Repayment of Debt
- - - - - -0.01 0.00 - - - -24
Repurchase of Common Equity
- -7.54 -6.86 -11 -7.47 -2.93 -9.80 -67 -26 -46 0.00
Other Financing Activities, net
-0.66 -1.21 -3.21 -1.73 -0.91 -3.28 -4.54 -2.23 -0.14 -1.08 -1.80
Effect of Exchange Rate Changes
-0.42 0.41 -0.14 -0.07 0.66 0.03 -0.03 -0.14 -0.31 0.36 0.02

Annual Balance Sheets for Angi

This table presents Angi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
296 1,467 1,808 1,922 2,368 2,012 1,908 1,856 1,831 1,680
Total Current Assets
64 262 474 500 978 585 484 487 495 366
Cash & Equivalents
36 222 337 391 813 428 321 364 416 304
Accounts Receivable
19 28 27 42 43 86 72 51 37 33
Other Current Assets
8.74 13 85 68 72 71 64 72 42 30
Plant, Property, & Equipment, net
24 53 71 103 109 118 153 110 80 99
Total Noncurrent Assets
208 1,152 1,263 1,318 1,282 1,309 1,271 1,259 1,256 1,215
Goodwill
171 770 895 884 892 916 883 886 883 890
Intangible Assets
11 329 304 252 210 194 178 171 168 167
Noncurrent Deferred & Refundable Income Taxes
15 51 41 - 86 123 138 148 169 126
Other Noncurrent Operating Assets
11 2.07 23 183 94 76 62 54 36 31
Total Liabilities & Shareholders' Equity
296 1,467 1,808 1,922 2,368 2,012 1,908 1,856 1,831 1,680
Total Liabilities
119 443 468 571 1,059 867 856 812 768 753
Total Current Liabilities
68 171 201 215 234 278 282 259 232 222
Accounts Payable
14 20 20 26 31 39 30 29 18 34
Accrued Expenses
34 75 106 117 148 186 183 179 171 166
Current Deferred Revenue
19 62 61 58 55 54 50 50 42 22
Total Noncurrent Liabilities
51 272 267 356 825 588 575 553 536 531
Long-Term Debt
0.00 258 245 232 712 495 495 496 497 498
Noncurrent Deferred & Payable Income Tax Liabilities
2.23 5.63 3.81 3.44 1.30 1.88 2.91 2.74 1.50 1.50
Other Noncurrent Operating Liabilities
2.25 5.89 17 121 112 92 76 54 38 31
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
163 1,003 1,322 1,324 1,283 1,146 1,051 1,045 1,063 927
Total Preferred & Common Equity
153 993 1,313 1,314 1,272 1,135 1,048 1,041 1,063 927
Total Common Equity
153 993 1,313 1,314 1,272 1,135 1,048 1,041 1,063 927
Common Stock
155 1,112 1,334 1,358 1,380 1,351 1,406 1,448 1,466 1,428
Retained Earnings
0.00 -122 -19 16 9.75 -62 -190 -231 -195 -151
Treasury Stock
- - 0.00 -58 -122 -158 -166 -177 -206 -356
Accumulated Other Comprehensive Income / (Loss)
-1.72 2.23 -1.86 -1.38 4.64 3.31 -1.17 1.19 -2.50 5.94

Quarterly Balance Sheets for Angi

This table presents Angi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
1,968 1,889 1,902 1,906 1,835 1,852 1,856 1,806 1,789 1,747 1,625
Total Current Assets
512 486 511 516 482 516 500 465 443 407 313
Cash & Equivalents
329 315 371 367 363 385 395 387 362 341 245
Accounts Receivable
103 92 78 77 61 66 52 40 45 38 37
Other Current Assets
81 67 62 72 58 65 52 38 36 28 31
Plant, Property, & Equipment, net
167 139 130 121 100 90 86 84 87 93 101
Total Noncurrent Assets
1,288 1,264 1,261 1,269 1,253 1,247 1,271 1,256 1,258 1,247 1,211
Goodwill
903 884 886 883 885 885 888 886 890 890 889
Intangible Assets
180 176 173 170 171 171 171 168 169 169 167
Noncurrent Deferred & Refundable Income Taxes
137 144 149 158 147 147 172 170 167 157 125
Other Noncurrent Operating Assets
69 60 53 56 50 44 40 33 32 31 29
Total Liabilities & Shareholders' Equity
1,968 1,889 1,902 1,906 1,835 1,852 1,856 1,806 1,789 1,747 1,625
Total Liabilities
880 841 860 860 792 808 787 756 787 753 711
Total Current Liabilities
300 270 303 304 242 261 244 216 248 215 209
Accounts Payable
50 31 37 53 31 21 33 29 40 39 35
Accrued Expenses
194 189 212 196 162 189 160 152 175 146 153
Current Deferred Revenue
55 50 54 55 50 51 50 35 33 30 21
Total Noncurrent Liabilities
580 570 557 557 550 548 543 540 539 538 501
Long-Term Debt
495 495 496 496 496 496 497 497 497 497 471
Noncurrent Deferred & Payable Income Tax Liabilities
1.66 2.93 3.01 2.92 3.03 3.30 2.05 1.53 1.61 1.02 1.46
Other Noncurrent Operating Liabilities
83 72 58 58 50 48 44 42 40 40 28
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,088 1,048 1,042 1,045 1,043 1,044 1,070 1,049 1,002 994 915
Total Preferred & Common Equity
1,086 1,045 1,038 1,042 1,039 1,040 1,070 1,049 1,002 994 915
Total Common Equity
1,086 1,045 1,038 1,042 1,039 1,040 1,070 1,049 1,002 994 915
Common Stock
1,394 1,417 1,427 1,438 1,455 1,464 1,463 1,445 1,449 1,456 1,425
Retained Earnings
-137 -205 -220 -225 -233 -229 -194 -180 -169 -158 -160
Treasury Stock
-166 -166 -170 -170 -184 -195 -203 -217 -285 -310 -356
Accumulated Other Comprehensive Income / (Loss)
-5.21 -0.71 1.12 -0.94 0.44 0.26 3.28 0.38 6.35 5.82 5.76

Annual Metrics And Ratios for Angi

This table displays calculated financial ratios and metrics derived from Angi's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 43,150,575.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 43,150,575.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.02
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 38.12% 47.60% 53.76% 17.13% 10.69% 10.31% 8.96% -22.99% -12.78% -13.04%
EBITDA Growth
0.00% 312.80% -409.45% 255.58% -16.43% -36.56% -94.73% 258.81% 454.97% 37.87% 0.94%
EBIT Growth
0.00% 1,288.15% -724.59% 155.96% -44.71% -114.11% -1,005.95% -5.71% 89.16% 598.65% 106.22%
NOPAT Growth
0.00% 1,137.25% -1,009.19% 168.34% -42.66% -110.99% -966.54% -11.34% 64.96% 316.55% 14.15%
Net Income Growth
0.00% 366.04% -1,083.23% 174.15% -54.44% -115.23% -1,210.78% -81.55% 68.50% 191.41% 18.95%
EPS Growth
0.00% 0.00% -900.00% 162.50% -53.33% -114.29% -1,300.00% -85.71% 69.23% 187.50% 32.39%
Operating Cash Flow Growth
0.00% 167.80% -12.68% 434.87% -4.26% -12.02% -96.70% 335.96% 287.33% 48.73% -32.62%
Free Cash Flow Firm Growth
0.00% 0.00% -465.63% 90.91% 181.04% -42.48% -339.22% 51.26% 126.54% 464.01% -7.82%
Invested Capital Growth
0.00% 0.00% 475.85% 14.95% -2.63% -3.86% 4.59% -0.32% -2.61% -2.83% -1.91%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 5.18% 3.31% 2.64% -0.59% -1.96% -1.02% -2.67% -2.56%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 64.82% -12.21% -19.25% -80.53% 230.39% 36.34% -6.31% -0.78%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 446.06% -35.48% -190.80% -34.68% 13.65% 81.59% -16.02% 5.47%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 206.77% -38.08% -115.19% -29.88% 12.30% 39.56% 0.40% 23.18%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 542.87% -51.07% -137.21% -9.03% -27.36% 54.21% 13.07% 24.09%
EPS Q/Q Growth
0.00% 0.00% 0.00% 400.00% -50.00% -200.00% -27.27% -30.00% 55.56% 0.00% 14.63%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 60.15% -15.04% -8.21% -84.90% 425.31% 0.32% 28.57% -8.65%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 239.60% -56.25% -7.08% 60.44% -73.84% 69.29% 18.21%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 14.35% 0.40% 2.22% 1.75% -3.72% 0.19% -2.37% -2.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
93.65% 94.82% 95.37% 95.08% 96.49% 88.20% 83.04% 80.88% 95.40% 95.14% 95.40%
EBITDA Margin
2.34% 7.00% -14.68% 14.85% 10.60% 6.07% 0.29% 0.95% 6.88% 10.88% 12.63%
Operating Margin
-0.43% 4.82% -20.08% 5.64% 2.91% -0.43% -4.19% -4.29% -1.95% 1.85% 6.35%
EBIT Margin
-0.54% 4.68% -19.81% 7.21% 3.40% -0.43% -4.35% -4.22% -0.59% 3.40% 8.05%
Profit (Net Income) Margin
-1.11% 2.13% -14.19% 6.85% 2.66% -0.37% -4.35% -7.25% -2.97% 3.11% 4.25%
Tax Burden Percent
178.55% 47.32% 68.04% 110.69% 104.96% 27.82% 75.06% 135.35% 142.91% 183.53% 70.10%
Interest Burden Percent
113.84% 96.17% 105.30% 85.76% 74.54% 303.52% 133.35% 127.01% 349.50% 49.89% 75.34%
Effective Tax Rate
0.00% 52.68% 0.00% -10.69% -4.96% 0.00% 0.00% 0.00% 0.00% -83.53% 29.90%
Return on Invested Capital (ROIC)
0.00% 12.18% -16.38% 6.11% 3.32% -0.38% -4.01% -4.37% -1.56% 3.46% 4.05%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -2.02% -19.60% -21.16% 7.57% 0.25% 50.63% -71.64% -16.63% 0.34% 2.58%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.12% -1.03% 0.44% -0.69% -0.03% -1.73% -7.28% -2.29% 0.03% 0.36%
Return on Equity (ROE)
0.00% 12.05% -17.41% 6.56% 2.63% -0.40% -5.74% -11.65% -3.85% 3.50% 4.40%
Cash Return on Invested Capital (CROIC)
0.00% -187.82% -157.19% -7.80% 5.99% 3.56% -8.49% -4.06% 1.09% 6.33% 5.98%
Operating Return on Assets (OROA)
0.00% 7.90% -16.55% 4.99% 2.42% -0.30% -3.22% -3.80% -0.43% 2.18% 4.73%
Return on Assets (ROA)
0.00% 3.60% -11.86% 4.73% 1.89% -0.25% -3.22% -6.53% -2.14% 2.00% 2.50%
Return on Common Equity (ROCE)
0.00% 10.46% -16.62% 6.39% 2.56% -0.39% -5.63% -11.58% -3.83% 3.49% 4.40%
Return on Equity Simple (ROE_SIMPLE)
0.00% 6.94% -10.52% 5.90% 2.69% -0.42% -6.21% -12.21% -3.87% 3.47% 0.00%
Net Operating Profit after Tax (NOPAT)
-1.10 11 -104 71 41 -4.46 -48 -53 -19 40 46
NOPAT Margin
-0.30% 2.28% -14.06% 6.25% 3.06% -0.30% -2.94% -3.00% -1.37% 3.39% 4.45%
Net Nonoperating Expense Percent (NNEP)
0.00% 14.19% 3.22% 27.27% -4.25% -0.62% -54.64% 67.27% 15.08% 3.12% 1.47%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.42% -1.20% 2.58% 3.22%
Cost of Revenue to Revenue
6.35% 5.18% 4.63% 4.92% 3.51% 11.80% 16.96% 19.12% 4.60% 4.86% 4.60%
SG&A Expenses to Revenue
24.00% 22.07% 40.80% 28.57% 26.26% 25.48% 24.39% 25.34% 26.45% 27.00% 25.51%
R&D to Revenue
4.66% 4.13% 6.51% 5.40% 4.84% 4.69% 4.38% 4.18% 7.11% 8.05% 8.48%
Operating Expenses to Revenue
94.08% 89.99% 115.45% 89.43% 93.58% 88.63% 87.23% 85.16% 97.35% 93.29% 89.05%
Earnings before Interest and Taxes (EBIT)
-1.97 23 -146 82 45 -6.37 -70 -74 -8.07 40 83
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.46 35 -108 168 141 89 4.70 17 93 129 130
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 6.07 3.24 5.18 4.08 1.13 1.21 0.78 0.60
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 69.94 23.84 38.62 186.92 0.00 0.00 70.56 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 7.04 3.21 4.49 2.86 0.67 0.93 0.70 0.54
Price to Earnings (P/E)
0.00 0.00 0.00 103.06 122.28 0.00 0.00 0.00 0.00 22.93 12.73
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.97% 0.82% 0.00% 0.00% 0.00% 0.00% 4.36% 7.86%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 6.38 3.44 5.59 3.88 1.13 1.19 0.79 0.67
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 6.97 3.13 4.42 2.91 0.77 1.03 0.76 0.73
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 46.93 29.53 72.70 1,001.99 80.89 14.96 7.03 5.78
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 96.66 91.93 0.00 0.00 0.00 0.00 22.51 9.06
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 111.58 102.31 0.00 0.00 0.00 0.00 22.55 16.40
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 35.28 19.38 34.40 757.67 50.34 13.34 5.81 7.16
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 56.71 153.99 0.00 0.00 107.36 12.33 11.10
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.27 0.19 0.18 0.54 0.43 0.47 0.47 0.47 0.54
Long-Term Debt to Equity
0.00 0.00 0.25 0.18 0.17 0.54 0.43 0.47 0.47 0.47 0.54
Financial Leverage
0.00 0.06 0.05 -0.02 -0.09 -0.11 -0.03 0.10 0.14 0.10 0.14
Leverage Ratio
0.00 1.68 1.47 1.39 1.39 1.61 1.78 1.78 1.80 1.75 1.76
Compound Leverage Factor
0.00 1.61 1.55 1.19 1.03 4.90 2.38 2.27 6.28 0.87 1.33
Debt to Total Capital
0.00% 0.00% 20.99% 16.18% 15.40% 35.24% 30.15% 32.02% 32.20% 31.86% 34.92%
Short-Term Debt to Total Capital
0.00% 0.00% 1.06% 0.86% 0.86% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 19.92% 15.32% 14.53% 35.24% 30.15% 32.02% 32.20% 31.86% 34.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 13.19% 2.39% 1.70% 2.25% 1.83% 0.67% 0.19% 0.24% 0.00% 0.00%
Common Equity to Total Capital
0.00% 86.81% 76.58% 82.12% 82.35% 62.94% 69.18% 67.78% 67.56% 68.14% 65.08%
Debt to EBITDA
0.00 0.00 -2.52 1.54 1.75 7.99 105.34 29.40 5.31 3.85 3.82
Net Debt to EBITDA
0.00 0.00 -0.47 -0.61 -1.03 -1.69 14.15 10.34 1.41 0.62 1.49
Long-Term Debt to EBITDA
0.00 0.00 -2.39 1.46 1.65 7.99 105.34 29.40 5.31 3.85 3.82
Debt to NOPAT
0.00 0.00 -2.63 3.66 6.06 -159.79 -10.40 -9.36 -26.74 12.37 10.85
Net Debt to NOPAT
0.00 0.00 -0.49 -1.46 -3.57 33.75 -1.40 -3.29 -7.12 2.00 4.23
Long-Term Debt to NOPAT
0.00 0.00 -2.50 3.46 5.72 -159.79 -10.40 -9.36 -26.74 12.37 10.85
Altman Z-Score
0.00 0.00 0.00 11.16 5.43 4.73 4.03 1.61 1.62 1.39 1.20
Noncontrolling Interest Sharing Ratio
0.00% 13.19% 4.56% 2.48% 2.35% 2.74% 1.95% 0.63% 0.32% 0.18% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 0.94 1.53 2.36 2.33 4.18 2.10 1.72 1.88 2.14 1.65
Quick Ratio
0.00 0.81 1.46 1.93 2.01 3.88 1.85 1.40 1.61 1.96 1.51
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -176 -993 -90 73 42 -101 -49 13 73 68
Operating Cash Flow to CapEx
175.86% 287.49% 155.84% 611.80% 311.26% 359.11% 8.88% 23.47% 219.82% 309.34% 176.73%
Free Cash Flow to Firm to Interest Expense
0.00 -196.46 -128.42 -7.77 6.37 2.97 -4.29 -2.44 0.65 3.64 3.31
Operating Cash Flow to Interest Expense
65.75 53.57 5.41 19.25 18.63 13.29 0.26 1.35 5.21 7.73 5.13
Operating Cash Flow Less CapEx to Interest Expense
28.36 34.94 1.94 16.10 12.65 9.59 -2.71 -4.39 2.84 5.23 2.23
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 1.69 0.84 0.69 0.71 0.68 0.74 0.90 0.72 0.64 0.59
Accounts Receivable Turnover
0.00 26.68 31.48 40.91 38.48 34.61 25.02 22.29 22.08 27.00 29.56
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 21.10 19.14 18.24 15.22 13.84 14.26 13.03 10.37 12.53 11.54
Accounts Payable Turnover
0.00 1.80 2.00 2.80 2.02 6.10 7.89 9.74 2.09 2.41 1.81
Days Sales Outstanding (DSO)
0.00 13.68 11.59 8.92 9.49 10.54 14.59 16.37 16.53 13.52 12.35
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 203.01 182.81 130.42 180.84 59.81 46.29 37.46 174.66 151.46 201.41
Cash Conversion Cycle (CCC)
0.00 -189.33 -171.22 -121.50 -171.35 -49.27 -31.70 -21.09 -158.13 -137.95 -189.06
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 187 1,077 1,238 1,205 1,159 1,212 1,208 1,177 1,143 1,121
Invested Capital Turnover
0.00 5.34 1.17 0.98 1.09 1.24 1.37 1.46 1.14 1.02 0.91
Increase / (Decrease) in Invested Capital
0.00 187 890 161 -33 -47 53 -3.86 -32 -33 -22
Enterprise Value (EV)
0.00 0.00 0.00 7,892 4,150 6,481 4,704 1,363 1,399 906 752
Market Capitalization
0.00 0.00 0.00 7,968 4,259 6,595 4,627 1,186 1,263 825 558
Book Value per Share
$0.00 $0.35 $2.31 $2.65 $2.61 $2.55 $2.26 $2.08 $2.05 $2.14 $21.49
Tangible Book Value per Share
$0.00 ($0.07) ($0.25) $0.23 $0.36 $0.34 $0.05 ($0.03) ($0.03) $0.02 ($3.01)
Total Capital
0.00 176 1,296 1,599 1,596 2,021 1,640 1,547 1,541 1,560 1,425
Total Debt
0.00 0.00 272 259 246 712 495 495 496 497 498
Total Long-Term Debt
0.00 0.00 258 245 232 712 495 495 496 497 498
Net Debt
0.00 -36 51 -103 -145 -150 66 174 132 80 194
Capital Expenditures (CapEx)
10 17 27 37 69 52 70 115 48 50 59
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -40 -116 -75 -92 -119 -122 -119 -135 -153 -160
Debt-free Net Working Capital (DFNWC)
0.00 -3.84 105 287 299 744 307 202 229 263 144
Net Working Capital (NWC)
0.00 -3.84 91 273 285 744 307 202 229 263 144
Net Nonoperating Expense (NNE)
2.90 0.75 1.02 -6.77 5.25 0.92 23 75 22 3.32 2.02
Net Nonoperating Obligations (NNO)
0.00 11 53 -102 -145 -150 66 157 132 80 194
Total Depreciation and Amortization (D&A)
10 12 38 87 95 96 75 91 102 89 47
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -8.06% -15.81% -6.65% -6.92% -8.08% -7.51% -6.73% -9.97% -12.91% -15.50%
Debt-free Net Working Capital to Revenue
0.00% -0.77% 14.27% 25.32% 22.53% 50.69% 18.93% 11.47% 16.82% 22.23% 13.97%
Net Working Capital to Revenue
0.00% -0.77% 12.40% 24.10% 21.49% 50.69% 18.93% 11.47% 16.82% 22.23% 13.97%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.03 ($0.24) $0.16 $0.07 ($0.01) ($0.14) ($0.26) ($0.08) $0.07 $0.96
Adjusted Weighted Average Basic Shares Outstanding
0.00 437.60M 478.25M 504.04M 501.14M 500.05M 501.63M 504.78M 502.03M 498.45M 40.10M
Adjusted Diluted Earnings per Share
$0.00 $0.03 ($0.24) $0.15 $0.07 ($0.01) ($0.14) ($0.26) ($0.08) $0.07 $0.94
Adjusted Weighted Average Diluted Shares Outstanding
0.00 437.60M 478.25M 504.04M 501.14M 500.05M 501.63M 504.78M 502.03M 498.45M 40.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.03 $0.00 $0.00 $0.07 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 437.60M 478.25M 504.04M 501.14M 500.05M 501.63M 504.78M 502.03M 498.45M 40.10M
Normalized Net Operating Profit after Tax (NOPAT)
-1.10 17 -104 45 27 -4.46 -48 -53 -19 15 55
Normalized NOPAT Margin
-0.30% 3.38% -14.06% 3.95% 2.04% -0.30% -2.94% -3.00% -1.37% 1.29% 5.32%
Pre Tax Income Margin
-0.62% 4.50% -20.86% 6.18% 2.54% -1.32% -5.80% -5.36% -2.08% 1.69% 6.07%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-7.23 26.13 -18.86 7.02 3.93 -0.45 -3.00 -3.70 -0.40 2.00 4.05
NOPAT to Interest Expense
-4.04 12.73 -13.38 6.09 3.53 -0.31 -2.02 -2.63 -0.92 1.99 2.24
EBIT Less CapEx to Interest Expense
-44.62 7.49 -22.33 3.88 -2.06 -4.15 -5.98 -9.44 -2.77 -0.50 1.15
NOPAT Less CapEx to Interest Expense
-41.43 -5.90 -16.85 2.94 -2.46 -4.02 -5.00 -8.37 -3.29 -0.51 -0.66
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 1.97% -12.24% 7.82% 0.20% -79.60% -39.52% 0.00% 0.00% 43.47% 0.00%
Augmented Payout Ratio
0.00% 1.97% -12.24% 7.82% 161.34% -1,263.57% -89.74% -6.36% -27.12% 121.10% 339.20%

Quarterly Metrics And Ratios for Angi

This table displays calculated financial ratios and metrics derived from Angi's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - 44,342,162.00 43,150,575.00 40,104,748.00
DEI Adjusted Shares Outstanding
- - - - - - - - 44,342,162.00 43,150,575.00 40,104,748.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.24 0.17 -0.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-29.48% -4.44% -14.09% -10.37% -15.52% -10.84% -19.48% -11.71% -10.48% -10.12% -3.16%
EBITDA Growth
157.66% 48.04% 49.43% 163.17% 48.27% -23.42% 12.01% -13.95% 20.49% -10.96% -70.30%
EBIT Growth
70.26% 235.53% 201.78% 234.91% 447.33% -58.30% 244.88% 63.49% 87.53% 78.43% -117.58%
NOPAT Growth
28.90% 134.21% 78.28% 140.02% 673.98% -367.00% 1,023.01% 156.26% -64.85% 253.78% -143.38%
Net Income Growth
69.68% 89.59% 91.22% 128.23% 768.87% 76.81% 1,247.00% 166.56% -70.01% 661.74% -159.43%
EPS Growth
66.67% 90.91% 100.00% 133.33% 800.00% 0.00% 1,100.00% 228.57% -67.14% 0.00% -173.33%
Operating Cash Flow Growth
157.51% 2.14% 5.31% 10.75% 180.57% 149.50% -113.96% -8.89% -32.14% -24.86% -475.10%
Free Cash Flow Firm Growth
204.94% 1,250.69% 736.21% -72.21% -53.34% -20.10% -18.19% 90.65% -10.88% 16.03% -64.17%
Invested Capital Growth
-6.41% -2.61% -3.32% -0.97% -0.29% -2.83% -1.40% -1.62% -1.71% -1.91% -1.55%
Revenue Q/Q Growth
-0.10% -14.46% 9.14% 3.19% -5.84% -9.72% -8.20% 13.14% -4.52% -9.36% -1.09%
EBITDA Q/Q Growth
46.19% 75.33% -20.00% 22.65% -17.64% -9.44% 22.44% -5.78% 15.32% -39.20% -55.04%
EBIT Q/Q Growth
61.05% 431.62% -53.30% 91.07% 0.28% -60.18% 352.05% -9.42% 15.03% -62.12% -144.54%
NOPAT Q/Q Growth
48.89% 142.29% -136.11% 360.44% 633.10% -119.67% 345.72% -27.69% 0.56% -13.93% -169.32%
Net Income Q/Q Growth
63.49% -4.88% 76.25% 410.40% 765.04% -103.64% 1,274.65% -27.86% -2.68% -31.88% -224.28%
EPS Q/Q Growth
66.67% 0.00% 100.00% 0.00% 600.00% -114.29% 3,100.00% -23.33% 0.00% -21.74% -222.22%
Operating Cash Flow Q/Q Growth
-80.53% 45.63% 313.96% 181.18% -50.69% 29.50% -107.78% 1,934.92% -63.27% 43.39% -159.51%
Free Cash Flow Firm Q/Q Growth
33.64% -54.78% 7.17% -59.76% 124.35% -22.56% 17.02% -6.22% 4.87% 0.82% -63.86%
Invested Capital Q/Q Growth
0.63% 0.19% -0.05% -1.72% 1.32% -2.37% 1.43% -1.94% 1.22% -2.56% 1.80%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
96.11% 94.26% 95.91% 95.51% 95.03% 93.96% 94.71% 95.28% 95.31% 96.34% 95.93%
EBITDA Margin
6.02% 12.35% 10.17% 12.08% 10.57% 10.60% 14.14% 11.78% 14.23% 9.54% 4.34%
Operating Margin
-2.24% 2.54% 0.89% 2.92% 2.63% 0.81% 8.13% 6.35% 8.20% 2.47% -3.97%
EBIT Margin
-1.13% 4.38% 2.36% 4.37% 4.65% 2.05% 10.10% 8.08% 9.74% 4.07% -1.83%
Profit (Net Income) Margin
-1.51% -1.85% -0.43% 1.30% 11.92% -0.48% 6.14% 3.92% 3.99% 3.00% -3.77%
Tax Burden Percent
58.69% -68.16% -60.92% 46.90% 404.10% -287.05% 76.34% 62.48% 50.98% 160.68% 92.60%
Interest Burden Percent
226.81% 61.76% 30.03% 63.36% 63.43% 8.16% 79.69% 77.54% 80.41% 45.87% 222.11%
Effective Tax Rate
0.00% 69.48% 160.92% 53.10% -304.10% 387.05% 23.66% 37.52% 49.02% -60.68% 0.00%
Return on Invested Capital (ROIC)
-1.77% 0.88% -0.59% 1.50% 11.06% -2.37% 5.99% 3.77% 3.81% 3.61% -2.47%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.62% -4.57% -0.37% 1.31% 14.33% 2.27% 5.85% 3.65% 3.42% 1.91% -3.87%
Return on Net Nonoperating Assets (RNNOA)
-0.22% -0.63% -0.05% 0.15% 1.56% 0.23% 0.68% 0.44% 0.43% 0.26% -0.66%
Return on Equity (ROE)
-2.00% 0.25% -0.65% 1.65% 12.62% -2.14% 6.67% 4.21% 4.24% 3.88% -3.14%
Cash Return on Invested Capital (CROIC)
4.10% 1.09% 2.62% 1.20% 3.70% 6.33% 6.15% 7.01% 4.94% 5.98% 3.43%
Operating Return on Assets (OROA)
-0.80% 3.17% 1.66% 2.96% 3.01% 1.32% 6.24% 4.83% 5.72% 2.39% -1.09%
Return on Assets (ROA)
-1.07% -1.33% -0.30% 0.88% 7.72% -0.31% 3.80% 2.34% 2.34% 1.76% -2.25%
Return on Common Equity (ROCE)
-1.99% 0.25% -0.64% 1.64% 12.60% -2.14% 6.65% 4.20% 4.24% 3.88% -3.14%
Return on Equity Simple (ROE_SIMPLE)
-8.45% 0.00% -2.56% -0.78% 3.05% 0.00% 5.08% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-5.50 2.33 -1.65 4.31 32 -6.21 15 11 11 9.56 -6.62
NOPAT Margin
-1.57% 0.77% -0.54% 1.37% 10.65% -2.32% 6.21% 3.97% 4.18% 3.97% -2.78%
Net Nonoperating Expense Percent (NNEP)
-0.15% 5.45% -0.22% 0.19% -3.28% -4.64% 0.14% 0.12% 0.39% 1.70% 1.40%
Return On Investment Capital (ROIC_SIMPLE)
- 0.15% - - - -0.40% 0.99% 0.74% 0.74% 0.67% -0.48%
Cost of Revenue to Revenue
3.89% 5.74% 4.09% 4.49% 4.97% 6.04% 5.29% 4.72% 4.69% 3.66% 4.07%
SG&A Expenses to Revenue
28.10% 23.58% 28.00% 26.77% 25.89% 27.36% 23.31% 26.63% 26.13% 25.78% 24.33%
R&D to Revenue
6.12% 8.05% 7.78% 7.86% 8.19% 8.40% 11.01% 8.48% 7.81% 6.62% 4.38%
Operating Expenses to Revenue
98.35% 91.72% 95.02% 92.59% 92.39% 93.15% 86.57% 88.92% 87.11% 93.87% 99.90%
Earnings before Interest and Taxes (EBIT)
-3.97 13 7.20 14 14 5.49 25 22 26 9.80 -4.37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
21 37 31 38 31 28 35 33 38 23 10
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.96 1.21 1.27 0.93 1.20 0.78 0.73 0.73 0.73 0.60 0.30
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 125.74 70.56 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.73 0.93 1.01 0.76 1.06 0.70 0.68 0.67 0.68 0.54 0.27
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 40.55 22.93 14.56 12.23 20.41 12.73 13.91
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 2.47% 4.36% 6.87% 8.18% 4.90% 7.86% 7.19%
Enterprise Value to Invested Capital (EV/IC)
0.97 1.19 1.24 0.93 1.19 0.79 0.76 0.76 0.76 0.67 0.44
Enterprise Value to Revenue (EV/Rev)
0.83 1.03 1.11 0.85 1.14 0.76 0.78 0.80 0.83 0.73 0.49
Enterprise Value to EBITDA (EV/EBITDA)
16.55 14.96 14.00 8.47 10.09 7.03 6.76 6.95 6.69 5.78 4.83
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 234.12 35.79 28.96 22.51 15.18 13.02 11.16 9.06 9.32
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 401.99 34.69 22.55 15.87 14.06 23.58 16.40 23.35
Enterprise Value to Operating Cash Flow (EV/OCF)
10.86 13.34 15.24 10.64 11.44 5.81 6.73 6.94 7.63 7.16 5.56
Enterprise Value to Free Cash Flow (EV/FCFF)
22.80 107.36 46.29 77.26 31.98 12.33 12.24 10.79 15.32 11.10 12.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.47 0.48 0.48 0.46 0.47 0.47 0.50 0.50 0.54 0.52
Long-Term Debt to Equity
0.47 0.47 0.48 0.48 0.46 0.47 0.47 0.50 0.50 0.54 0.52
Financial Leverage
0.14 0.14 0.14 0.11 0.11 0.10 0.12 0.12 0.13 0.14 0.17
Leverage Ratio
1.82 1.80 1.78 1.80 1.78 1.75 1.74 1.78 1.75 1.76 1.75
Compound Leverage Factor
4.12 1.11 0.53 1.14 1.13 0.14 1.39 1.38 1.40 0.81 3.88
Debt to Total Capital
32.17% 32.20% 32.24% 32.22% 31.71% 31.86% 32.15% 33.16% 33.35% 34.92% 34.01%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
32.17% 32.20% 32.24% 32.22% 31.71% 31.86% 32.15% 33.16% 33.35% 34.92% 34.01%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.23% 0.24% 0.26% 0.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
67.59% 67.56% 67.50% 67.49% 68.29% 68.14% 67.85% 66.84% 66.65% 65.08% 65.99%
Debt to EBITDA
7.23 5.31 4.78 3.90 3.61 3.85 3.82 3.99 3.79 3.82 4.54
Net Debt to EBITDA
1.88 1.41 1.28 0.88 0.74 0.62 0.85 1.08 1.20 1.49 2.18
Long-Term Debt to EBITDA
7.23 5.31 4.78 3.90 3.61 3.85 3.82 3.99 3.79 3.82 4.54
Debt to NOPAT
-16.16 -26.74 -54.95 184.92 12.41 12.37 8.98 8.06 13.37 10.85 21.95
Net Debt to NOPAT
-4.20 -7.12 -14.72 41.55 2.53 2.00 2.00 2.19 4.21 4.23 10.56
Long-Term Debt to NOPAT
-16.16 -26.74 -54.95 184.92 12.41 12.37 8.98 8.06 13.37 10.85 21.95
Altman Z-Score
1.38 1.66 1.70 1.42 1.68 1.33 1.30 1.21 1.23 1.05 0.79
Noncontrolling Interest Sharing Ratio
0.30% 0.32% 0.35% 0.38% 0.17% 0.18% 0.19% 0.21% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.70 1.88 1.99 1.98 2.05 2.14 2.15 1.79 1.89 1.65 1.50
Quick Ratio
1.46 1.61 1.75 1.73 1.84 1.96 1.98 1.64 1.76 1.51 1.35
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
75 34 39 16 35 27 32 30 31 31 11
Operating Cash Flow to CapEx
79.91% 138.32% 174.30% 495.75% 255.44% 311.09% -24.91% 466.29% 130.74% 161.24% -114.08%
Free Cash Flow to Firm to Interest Expense
14.89 6.73 7.69 3.09 6.93 5.37 6.28 5.89 6.15 5.93 2.13
Operating Cash Flow to Interest Expense
2.19 3.19 4.43 12.44 6.13 7.94 -0.62 11.31 4.14 5.67 -3.36
Operating Cash Flow Less CapEx to Interest Expense
-0.55 0.88 1.89 9.93 3.73 5.38 -3.10 8.88 0.97 2.15 -6.30
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.71 0.72 0.70 0.68 0.65 0.64 0.62 0.60 0.59 0.59 0.60
Accounts Receivable Turnover
15.23 22.08 17.09 17.57 18.78 27.00 22.23 19.59 23.31 29.56 26.28
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
9.51 10.37 10.95 11.60 11.77 12.53 12.25 12.29 11.84 11.54 11.04
Accounts Payable Turnover
0.91 2.09 1.89 1.99 1.36 2.41 1.96 1.88 1.52 1.81 1.38
Days Sales Outstanding (DSO)
23.96 16.53 21.35 20.77 19.43 13.52 16.42 18.63 15.66 12.35 13.89
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
401.55 174.66 193.32 183.51 267.46 151.46 186.02 194.20 239.95 201.41 263.73
Cash Conversion Cycle (CCC)
-377.59 -158.13 -171.96 -162.73 -248.03 -137.95 -169.60 -175.57 -224.28 -189.06 -249.84
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,174 1,177 1,176 1,156 1,171 1,143 1,160 1,137 1,151 1,121 1,142
Invested Capital Turnover
1.13 1.14 1.09 1.10 1.04 1.02 0.96 0.95 0.91 0.91 0.89
Increase / (Decrease) in Invested Capital
-80 -32 -40 -11 -3.39 -33 -16 -19 -20 -22 -18
Enterprise Value (EV)
1,135 1,399 1,452 1,079 1,388 906 879 867 878 752 502
Market Capitalization
1,002 1,263 1,315 963 1,287 825 768 732 721 558 275
Book Value per Share
$2.06 $2.05 $2.07 $2.07 $2.14 $2.14 $2.10 $20.89 $22.42 $21.49 $22.81
Tangible Book Value per Share
($0.02) ($0.03) ($0.03) ($0.03) $0.02 $0.02 ($0.01) ($1.18) ($1.45) ($3.01) ($3.53)
Total Capital
1,541 1,541 1,539 1,541 1,566 1,560 1,546 1,499 1,492 1,425 1,386
Total Debt
496 496 496 496 497 497 497 497 497 498 471
Total Long-Term Debt
496 496 496 496 497 497 497 497 497 498 471
Net Debt
129 132 133 112 101 80 110 135 157 194 227
Capital Expenditures (CapEx)
14 12 13 13 12 13 12 12 16 19 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-155 -135 -124 -130 -139 -153 -137 -167 -149 -160 -140
Debt-free Net Working Capital (DFNWC)
212 229 240 255 256 263 249 195 192 144 104
Net Working Capital (NWC)
212 229 240 255 256 263 249 195 192 144 104
Net Nonoperating Expense (NNE)
-0.22 7.87 -0.34 0.22 -3.77 -4.93 0.16 0.14 0.50 2.33 2.35
Net Nonoperating Obligations (NNO)
129 132 133 112 101 80 110 135 157 194 227
Total Depreciation and Amortization (D&A)
25 24 24 24 18 23 9.95 10 12 13 15
Debt-free, Cash-free Net Working Capital to Revenue
-11.27% -9.97% -9.46% -10.19% -11.44% -12.91% -12.21% -15.35% -14.05% -15.50% -13.73%
Debt-free Net Working Capital to Revenue
15.45% 16.82% 18.31% 20.06% 21.02% 22.23% 22.14% 17.94% 18.17% 13.97% 10.18%
Net Working Capital to Revenue
15.45% 16.82% 18.31% 20.06% 21.02% 22.23% 22.14% 17.94% 18.17% 13.97% 10.18%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.01) ($0.01) $0.00 $0.01 $0.07 ($0.01) $0.30 $0.23 $0.24 $0.18 ($0.22)
Adjusted Weighted Average Basic Shares Outstanding
507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M 44.34M 43.15M 40.10M 40.45M
Adjusted Diluted Earnings per Share
($0.01) ($0.01) $0.00 $0.01 $0.07 ($0.01) $0.30 $0.23 $0.23 $0.18 ($0.22)
Adjusted Weighted Average Diluted Shares Outstanding
507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M 44.34M 43.15M 40.10M 40.45M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.18 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M 44.34M 43.15M 40.10M 40.45M
Normalized Net Operating Profit after Tax (NOPAT)
-5.50 5.34 1.90 6.43 5.47 1.52 15 11 11 4.16 3.82
Normalized NOPAT Margin
-1.57% 1.78% 0.62% 2.04% 1.84% 0.57% 6.21% 3.97% 4.18% 1.73% 1.60%
Pre Tax Income Margin
-2.57% 2.71% 0.71% 2.77% 2.95% 0.17% 8.05% 6.27% 7.83% 1.87% -4.07%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.79 2.62 1.43 2.73 2.73 1.09 4.92 4.45 5.10 1.85 -0.82
NOPAT to Interest Expense
-1.09 0.46 -0.33 0.85 6.26 -1.23 3.03 2.19 2.19 1.80 -1.24
EBIT Less CapEx to Interest Expense
-3.53 0.31 -1.11 0.22 0.34 -1.46 2.44 2.03 1.94 -1.67 -3.76
NOPAT Less CapEx to Interest Expense
-3.83 -1.84 -2.87 -1.65 3.86 -3.78 0.55 -0.24 -0.98 -1.72 -4.19
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 49.15% 43.47% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-3.86% -27.12% -66.82% -319.27% 151.06% 121.10% 59.22% 144.46% 298.93% 339.20% 703.24%

Financials Breakdown Chart

Key Financial Trends

Angi’s latest quarter shows a mixed picture: revenue held essentially flat year over year, but the company slipped back into a loss as operating costs and restructuring expenses outweighed gross profit. At the same time, Angi still generated a sizable gross profit margin and ended the quarter with a large cash balance, which helps cushion the weaker earnings trend.

What stands out over the last several years: Angi has made meaningful progress from the deep losses seen in 2022 and early 2023 to periods of profitability in 2024 and late 2025. However, the improvement has not been steady. Earnings remain volatile, marketing spend is high, and share repurchases continue to consume cash. The balance sheet is still supported by a strong equity base, but leverage remains significant.

  • Gross profit remains strong: Q1 2026 gross profit was $228.5 million on $238.2 million of revenue, implying a very high gross margin of roughly 96%.
  • Angi still has a solid liquidity cushion, with $244.6 million in cash and equivalents at the end of Q1 2026.
  • Revenue has been relatively stable recently, with Q1 2026 revenue of $238.2 million versus $240.8 million in Q4 2025 and $245.9 million in Q1 2025.
  • The company has shown it can generate positive operating cash flow in stronger quarters, including Q4 2025 and several periods in 2024.
  • Long-term debt has edged lower from prior periods, falling to $471.4 million in Q1 2026 from about $497.5 million in Q3 2025.
  • Q1 2026 operating revenue was nearly flat year over year, so top-line growth is not currently a major strength.
  • The company’s earnings have been inconsistent, swinging from a Q4 2025 profit of $7.2 million to a Q1 2026 loss of $9.0 million.
  • Marketing remains the largest operating expense and continues to account for a substantial portion of the cost structure.
  • Goodwill and intangible assets make up a large share of total assets, which is common for acquired platforms but worth monitoring.
  • Q1 2026 operating income was negative $9.5 million, showing that core operations were not profitable in the quarter.
  • Cash from operating activities was negative $17.9 million in Q1 2026, a sharp deterioration from positive $30.1 million in Q4 2025.
  • The company spent $23.7 million on debt repayment and another $1.8 million on other financing items in Q1 2026, pressuring cash further.
  • Share repurchases remain a recurring use of cash, including $66.6 million in Q2 2025 and $46.0 million in Q4 2025.
  • Despite improvement versus 2022 and early 2023, Angi still carries meaningful leverage with total liabilities of $710.5 million and long-term debt of $471.4 million.

Bottom line: Angi has improved materially from its weaker 2022–2023 performance and can still produce profitable quarters, but the business remains cyclical and cost-heavy. For retail investors, the key question is whether the company can sustain operating profitability and convert it into consistent free cash flow rather than relying on sporadic quarterly rebounds.

07/26/26 03:03 AM ETAI Generated. May Contain Errors.

Angi Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Angi's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 10 years, Angi's net income changed from -$4.00 million in 2015 to $43.83 million in 2025, a change of -1,196.9%. View Angi's forecast to see where analysts expect Angi to go next.

Angi's total operating income in 2025 was $65.41 million, based on the following breakdown:
  • Total Gross Profit: $983.10 million
  • Total Operating Expenses: $917.69 million

Over the last 10 years, Angi's total revenue changed from $361.20 million in 2015 to $1.03 billion in 2025, a change of 185.3%.

Angi's total liabilities were at $753.00 million at the end of 2025, a 1.9% decrease from 2024, and a 532.1% increase since 2016.

In the past 9 years, Angi's cash and equivalents has ranged from $36.38 million in 2016 to $812.71 million in 2020, and is currently $303.70 million as of their latest financial filing in 2025.

Over the last 10 years, Angi's book value per share changed from 0.00 in 2015 to 21.49 in 2025, a change of 2,149.1%.



Financial statements for NASDAQ:ANGI last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners